Medication Management

The Medicines Patent Pool said in a statement that it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics.

Justin Bates, chief executive officer of the Ontario Pharmacists Association, had some thoughts in response to a recent opinion piece, which he here relays in the form of a letter to the editor.

Ontario study finds med reviews lead to a reduction in fall-related fractures and an overall reduction in fall-related injuries in community-dwelling older adults.

Your patients may start asking more about psychedelics. While there have been some promising results from trials involving psychedelic-assisted therapy, many questions remain.

The child's mother said she found a tick and removed it forcibly without any regard for technique. All seemed well. Then, a week later, this rash developed on the site of the bite.

Afrouz Nikmanesh said the retail giant fired her for blowing the whistle on violations that included overcharging Medicare beneficiaries.

Earlier this month, Merck asked the U.S. Food and Drug Administration to OK molnupiravir, and a decision is expected within weeks.

But those in the profession would like more training on the issue.